Home > Products > Colds, Flu, Allergies & Fungus > Yamoa Powder

YAMOA POWDER

YAMOA POWDER has been used in Ghana for many years to treat respiratory allergies. It is a natural product from the Funtumia Elastica gum tree, and when taken on a relatively short-term basis, can help with the symptoms of conditions such as, asthma, hay fever, bronchitis, sinusitis and COPD, in many cases for the long term.

• Yamoa Powder is a natural herbal supplement that supports the respiratory and immune systems.
• Yamoa Powder originated from West Africa, and has been handed down throughout the generations.
• Yamoa Powder has been traditionally used by native African healers to promote recovery from respiratory and allergic conditions.
• Yamoa Powder is a totally natural substance made from the ground bark of a unique gum tree found in West Africa, it contains no other additives and is from a pristine location.

A Survey by Questionnaire

Dr. Nyjon K. Eccles BSc MBBS PhD MRCP, The Chiron Clinic, 121 Harley Street
& Jerry Yamoa, NHC Ltd.

200 Questionaires sent out. 120 Returned. 60% Response.
Number of Asthma patients: 70
Mean duration of Asthma: 16.4 years
Age Range: 1 - 68 years
Male patients: 49%; Female patients: 41%; Gender unknown: 10%
14 patients aged 1 - 29yrs; 40 patients aged 30 - 59yrs; 15 patients aged 60 - 89yrs

44% of patients who took part in the survey were Caucasian. 25% were African; 12% were Asian; 10% were Afro-Carribean and 9% were of undisclosed origin.

The reported number of attacks in one year experienced by the group before taking YamoaT was 78. Attacks dropped to 22 per year after YamoaT.

On average patients took some form of asthma medication 3.6 times a day before taking YamoaT Powder. The average number of times medication has been required on a daily basis since YamoaT has been taken is 1.7 times a day.

There were 3 hospital admissions amongst the group who responded to the survey before YamoaT was taken. Afterwards, there were none before the survey was completed.

The average peak flow rate reading taken before YamoaT was 350. The average taken since using YamoaT Powder was 420. This means an average improvement of 70.

12% of patients found no benefits from taking YamoaT. 19% experienced a mild improvemnt in their condition. 29% reported a CURE. 40% reported a marked improvement in their condition.

Thus 69%, that is 69 people in every 100, experienced AT LEAST a marked improvement in their asthma as a result of taking Yamoa Powder.

Indications show that greater benefits may be achieved the younger the patient. This may be because the condition has not been with younger patients as long as for those in the older group; they may not have the history of stress and illness that older people have, in which case younger immune systems may be stronger than old. The younger group most likely does not have other contributing factors such as life-long smoking history etc.

U.S. Asthma and Allergy Statistics

• In 1994, the estimated number of people with self-reported asthma in the United States was 14.6 million. The estimate for 1998 has risen to 17 million. [1,2,3]

• Asthma was diagnosed more often than any other illness of 468,000 U.S. hospital admissions in 1993. [1,3]

• In the United States in 1994, asthma affected an estimated 4.8 million children (under age 18) out of an estimated 68 million children. Asthmatic youngsters under age 15 were hospitalized 159,000 times in 1993, and stayed 3.4 days on average. [1,3]

• Asthma is only slightly more prevalent in African-American children than in white children. [1] African-American children with asthma, however, experience more severe disability and have more frequent hospitalizations than do white children. [4,5]

• Among 5-24 year olds, the asthma death rate nearly doubled from 1980 to 1993. In 1993, African Americans in this age group were 4 to 6 times more likely to die from asthma than whites; and males were 1.5 times at greater risk than females. [1,7]

• Overall, asthma treatment cost an estimated $6.2 billion in 1990; 43% of that total cost was associated with emergency room use, hospitalization, and death. Loss of school days, alone, caused decreased productivity that cost an estimated $1 billion. [8]

• Estimates from a skin test survey suggest that allergies affect more than 50 million people in the United States. [9]

• Allergy testing accounted for 1.4 million office visits to physicians in 1991. [10]

• Pollen allergy (hay fever or allergic rhinitis) affects an estimated 10% or 26 million Americans, not including those with asthma. [11] Allergic rhinitis is the reason for 9.2 million office visits to physicians yearly. [12]

• The estimated overall costs of allergic rhinitis in the United States in 1996 totalled $6 billion. [13]

• Allergic dermatitis (itchy rash) is the most common skin condition in children younger than 11 years of age. [14] The percentage of American children diagnosed with it has increased from 3 percent in the 1960s to 10 percent in the 1990s. [15]

• Urticaria (hives; raised areas of reddened skin that become itchy) and angioedema (swelling of throat tissues) together affect approximately 15 percent of the U.S. population every year. [15]

• More than 1,000 systemic allergic reactions to natural rubber latex, including 15 deaths, were reported to the FDA between 1988 and 1992. Followups showed the reactions were caused by residual rubber tree proteins in medical devices such as rubber gloves and catheters. Most (82 percent) allergic reactions to latex are caused by rubber additives. [16]

• Chronic sinusitis affects nearly 35 million people in the United States. [3]

• Allergic drug reactions, commonly caused by antibiotics such as penicillin and cephalosporins, occur in 2 to 3% of hospitalized patients. [17]

• Eight percent of children younger than 6 years old experience food intolerance(s). Researchers estimate that up to 2 to 4 percent of all children under 6 have food allergy. [18]

• A severe allergic reaction known as anaphylaxis occurs in 3.3 percent of the U.S. population as a result of insect stings. At least 40 deaths per year result from insect sting anaphylaxis. [19]

References

Centers for Disease Control and Prevention, CDC Surveillance Summaries, Morbidity and Mortality Weekly Report; 47(SS-1), April 24, 1998.

CDC, Forcasted State-Specific Estimates of Self-Reported Asthma Prevalence-United States, 1998; MMWR; 47(47):1022-1025, December 4, 1998.

CDC, Vital and Health Statistics, Current Estimates from the National Health Interview Survey, 1994 (U.S. Department of Health and Human Services, Public Health Service, National Center for Health Statistics): DHHS Pub. No. PHS 96-1521, December 1995.

CDC; Vital and Health Statistics, National Hospital Discharge Survey: Annual Summary, 1995 (US DHHS, CDC); DHHS Publication No. PHS 98-1794 (Series 13, no. 133), 1998.

Taylor, W.R., Newacheck, P.W.: Impact of Childhood Asthma on Health; Pediatrics; 90(5):657-662, 1992.

Evans, R.: Asthma Among Minority children: A Growing Problem; Chest; 101(6):368S-371S, 1992.

CDC, Asthma Mortality and Hospitalization Among children and Young Adults, 1980-1993; MMWR, 45(17):350-353, May 3, 1996.

Weiss, K.B., Gergen, P.J., Hodgson, T.A.: An Economic Evaluation of Asthma in the U.S. New England Journal of Medicine; 326:862-6, 1992.

Gergen, P.J., Turkeltaub, P.C., Kaovar, M.G.: The Prevalence of Allergic Skin Reactivity to Eight Common Allergens in the US Population: Results from the Second National Health and Nutrition Examination Survey; J. Allergy Clinical Immunol.: 800:669-79, 1987.

CDC, Vital and Health Statistics, National Ambulatory Medical Care Survey: 1991 Summary (US DHHS, PHS, NCHS); DHHS Publication No. PHS 94-1777; May 1994.

CDC, National Health Survey, Series 10, Prevalence of Selected Chronic Conditions: United States, 1990-92, DHHS Pub. No. 97-1522, January 1997.

CDC/NCHS Vital Health Statisticote

The Yamoa Story Thus Far...

In Africa it has been part of the culture for hundreds of years to practice traditional medicine. Right across this vast continent tribes would have a healer or shaman. These healers used knowledge passed down to them through the generations, but kept them as closely guarded secrets. The secrets of herbs, tree bark, roots, fruits and berries that were used for their healing qualities were, and still are, used throughout Africa and the rest of the world by indigenous peoples (`botanising' started the pharmaceutical industry, when the discovery of pain-killing properties in willow tree bark led to the invention of aspirin).

People would come from far and wide to receive Akua Asirifia's remedies. As a boy Jerry was used to seeing long lines of people, young and old, coming and going from his grandmother's house, many of whom went away never to return. That was the extent of Akua's fame, given that most people experienced dramatic relief from the painful and debilitating symptoms of asthma and bronchial irritation after using this powder. What was most astonishing was that treatment was in most cases one-off - most people who had suffered for years from asthma, hayfever and other respiratory problems were free of their lifetime's problem after taking the powdered bark of this gum tree.

Akua's success was brought to the attention of Dr. Miser, a Swiss doctor based at a nearby Presbyterian mission hospital in Agogo in the Ashanti region of Ghana. He acknowledged what he heard sceptically, as would most Western medical practitioners. However, as his patients continued to tell him that their symptoms had disappeared after taking the powder, he decided to investigate for himself.

Dr. Miser had suffered with mild asthma so he was somewhat intrigued and sought out Akua to try the powder. The result amazed him, and he returned to Akua to ask her permission to have the powder tested and asked Akua to disclose her secret, if it passed the testing.
Akua was concerned that if the secret of Yamoa was unveiled it would be open to abuse; it might be made available only for people who could afford it, or worse still it might be kept a secret from everyone by a pharmaceutical company with a vested interest in doing so. So Akua guarded the Yamoa secret. Somewhat dismayed, Dr. Miser would often send his incurable cases to her - and would continue to call round in person. Dr. Miser pressed Akua for her knowledge, but she refused on every occasion.

As Jerry grew older, he was drawn towards teaching which is what he went on to do. Jerry trained to be a primary school teacher, and his ambition was to create a life for himself in England.

Eventually he emigrated here, settling in South London. For many years Jerry worked for the Post Office where he was surprised to meet so many people suffering with asthma and hayfever which in Ghana he had seen his grandmother so easily alleviate. Remembering all that his grandmother had told him and the queues of people that received the remedy, Jerry travelled back to Ghana in 1994 and asked Akua to tell him her secret. It took much persuading by Jerry and other members of the family before Akua finally granted him the secret and let him bring the remedy to the UK.

After a tribal ceremony in Ghana, Jerry Yamoa, grandson of Akua Asirifia, finally received the knowledge of the source of the remedy for the benefit of others. Akua took Jerry to the forest and showed him the bark of a tree. She gave him sole responsibility for bringing the remedy to those who need it. Akua knew many secrets of natural remedies and Jerry was very impressed with her extensive knowledge of herbs, plants and tree barks. Akua died aged 107, pleased that her grandson would sustain her legacy.

On his return to England, Jerry asked 20 colleagues at the Nine Elms Postal Office who suffered from asthma and hayfever to try the powdered bark. All 20 reported that they were much improved. Some were convinced that their asthma had gone completely, others with hayfever had no symptoms at all after taking the month's course. For the first time, people were able to lead a normal life because of this mystery powder.

Jerry was overwhelmed with the results. They were remarkable and profound with a 90% success rate, and two years later the first group were still going strong and were not having to use other forms of medication.

Obviously word spread, and Jerry was soon back in Ghana arranging for a regular shipment of the powder. In the UK things were going well and Channel 4 Television took an interest in Yamoa Powder and showed a feature on the 'London Today' programme.

Realising that Yamoa Powder was even more effective than he remembered as a boy, he decided to find the best way to bring it to the people who needed it, and on the advice of some friends, Jerry approached Boots the Chemists and Glaxo-Wellcome but only hit brick walls.

In his naïvete Jerry thought that they would jump at the chance of helping so many sufferers, but as it was pointed out to him later, if you are a company making millions of pounds out of asthma and hayfever, would you give up all your profits on a one-off remedy that actually works?

Undeterred to bring Yamoa Powder to those who most need it, Jerry began to sell it by himself. It wasn't long before word soon spread and sales began to increase at a steady stream. Sufferers who had taken the powder were telling friends and family about his remarkable remedy and after a year 70% of Jerry's sales were all by word-of-mouth.

Understanding Jerry's plight, a herb company offered to help him reach out to health shops. However, Yamoa Powder has been treated with a certain amount scepticism by some shop owners, and it is quite apparent that there are two types of health shop; one that acknowledges its role as a source of information and help for people looking for alternatives to mainstream medicines and foods, and one that has jumped on the health bandwagon in the interests of profit, not people.

A number of prominent scientists have now shown interest in Yamoa Powder, and research is currently underway to determine why Yamoa works by a research team at an Pharmacy department in London university.

Supplement Facts

Size: 30 gram jar (powder)

Yamoa Powder Suggested Usage

Mix the entire contents of the 30gm bottle thoroughly with an average size jar of organic honey, about 1lb (454gm). Stir well until the powder is completely mixed; also stir the mixture each time you use it.

Adults: One 5 ml standard teaspoonful of the mixture twice a day for one month continuously OR take a ¼ of a 5ml spoon(teaspoon) of powder twice a day with a 6-ounce glass of water or organic fruit juice, or organic tea..

Children: Aged 2 to 12: Half a 5ml teaspoon twice a day for one month continuously.

Babies and toddlers up to the age of 2: YamoaT Powder is perfectly safe for toddlers and babies - it has no known side effects. However, the use of honey or jam is not recommended for very young children under 2 years old because of the high level of refined sugar and for babies the risk of Botulism (bacteria in honey).

It is recommended that for very young children under two years of age either a naturally sweetened jam - free of sugar and artificial sweetners (Xylitol sweetners are fine.) - or even an unsweetened bottle of baby food should be used instead of honey. Please note that diabetic jams usually have artificial sweeteners added, so they are best avoided.

Other Hints On Usage

1) The powder is bitter; hence the suggested organic honey mixture. If organic honey is unacceptable, any other product may be used provided it can be well stirred and that it will keep for a month once opened. 1lb (454gm) should be used as this ensures the right dosage. Please remember a child's dose is half a teaspoon, and that the mixture will be taken over approximately 2 months in all for a child.

2) If you are a diabetic, you are advised to mix it with a low glycemic carrier.

3) Most people find they get results within the first month. Yamoa pack sizes last approximately one month for adults (and inevitably twice as long for children). Research indicates optimum results over two month.

4) The twice daily dose should be at least 6 hours apart; it does not have to be at meal times but generally people find it easier to associate their Yamoa with these fixed times.

WARNING!
Please do NOT take Yamoa while on blood pressure medication.

Note to sufferers of latex allergy:  Consult a physician before using this product if you are sensitive to natural rubber latex.   Allergy warning NRLA cross-reactive .

We do not recommend you take Yamoa if you are pregnant or breastfeeding, or if you are on blood pressure medication. We also do not recommend mixing the powder with honey or another sweet carrier if you suffer from fungal infections in the respiratory tract.